Borregaard ASA (OSL:BRG)
Norway · Delayed Price · Currency is NOK 142.40
+3.20 (2.30%)
Jun 4, 2026, 1:40 PM CET
Revenue
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
BioSolutions Revenue | 4.28B | 4.40B | 4.24B | ||||||||||||
BioSolutions Revenue Growth | -2.55% | 3.65% | 7.53% | ||||||||||||
BioMaterials Revenue | 2.73B | 2.69B | 2.62B | ||||||||||||
BioMaterials Revenue Growth | 1.49% | 2.63% | 7.50% | ||||||||||||
Fine Chemicals Revenue | 711.00M | 670.00M | 799.00M | ||||||||||||
Fine Chemicals Revenue Growth | 6.12% | -16.14% | 1.65% | ||||||||||||
Eliminations From Revenue | -44.00M | -44.00M | -45.00M | ||||||||||||
Revenue (Total) | 7.68B | 7.71B | 7.62B | ||||||||||||
Revenue (Total) Growth | -0.40% | 1.26% | 6.80% |
Revenue by Geography
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Norway Revenue | - | 328.00M | 227.00M | ||||||||||||
Norway Revenue Growth | - | 44.49% | -18.64% | ||||||||||||
Rest of Europe Revenue | - | 3.12B | 3.25B | ||||||||||||
Rest of Europe Revenue Growth | - | -4.09% | 5.07% | ||||||||||||
Asia Revenue | - | 1.89B | 1.72B | ||||||||||||
Asia Revenue Growth | - | 9.66% | 1.24% | ||||||||||||
America Revenue | - | 2.17B | 2.24B | ||||||||||||
America Revenue Growth | - | -3.26% | 18.44% | ||||||||||||
Rest of World Revenue | - | 77.00M | 60.00M | ||||||||||||
Rest of World Revenue Growth | - | 28.33% | 5.26% | ||||||||||||
Other Operating Revenue | - | 133.00M | 115.00M | ||||||||||||
Other Operating Revenue Growth | - | 15.65% | 6.48% | ||||||||||||
Revenue (Total) | 7.68B | 7.71B | 7.62B | ||||||||||||
Revenue (Total) Growth | -0.40% | 1.26% | 6.80% |
EBITDA
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
BioSolutions EBITDA | 1.12B | 1.21B | 1.10B | ||||||||||||
BioSolutions EBITDA Growth | -7.36% | 9.51% | 20.66% | ||||||||||||
BioMaterials EBITDA | 484.00M | 495.00M | 434.00M | ||||||||||||
BioMaterials EBITDA Growth | -2.22% | 14.06% | -18.73% | ||||||||||||
Fine Chemicals EBITDA | 191.00M | 174.00M | 336.00M | ||||||||||||
Fine Chemicals EBITDA Growth | 9.77% | -48.21% | 1.21% | ||||||||||||
Operating Income (Other) | -599.00M | -591.00M | -591.00M | ||||||||||||
Operating Income (Total) | 1.20B | 1.29B | 1.28B | ||||||||||||
Operating Income (Total) Growth | -7.07% | 0.31% | -0.62% |
EBIT
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
BioSolutions Operating Profit | 807.00M | 896.00M | 791.00M | ||||||||||||
BioSolutions Operating Profit Growth | -9.93% | 13.27% | 18.59% | ||||||||||||
BioMaterials Operating Profit | 245.00M | 263.00M | 200.00M | ||||||||||||
BioMaterials Operating Profit Growth | -6.84% | 31.50% | -40.12% | ||||||||||||
Fine Chemicals Operating Profit | 144.00M | 128.00M | 292.00M | ||||||||||||
Fine Chemicals Operating Profit Growth | 12.50% | -56.16% | 0.69% | ||||||||||||
Operating Income (Total) | 1.20B | 1.29B | 1.28B | ||||||||||||
Operating Income (Total) Growth | -7.07% | 0.31% | -0.62% |
Key Performance Indicators
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
BioSolutions - Gross Average Sales Price per MTDS | - | 12.03K | 12.05K | ||||||||||||
BioSolutions - Gross Average Sales Price per MTDS Growth | - | -0.15% | 2.48% | ||||||||||||
BioSolutions - Specialities Sales Volume (MTDS in Thousands) | - | 91.00 | 85.00 | ||||||||||||
BioSolutions - Specialities Sales Volume (MTDS in Thousands) Growth | - | 7.06% | 16.44% | ||||||||||||
BioSolutions - Construction Sales Volume (MTDS in Thousands) | - | 97.00 | 97.00 | ||||||||||||
BioSolutions - Construction Sales Volume (MTDS in Thousands) Growth | - | - | -3.00% | ||||||||||||
BioSolutions - Industrial Sales Volume (MTDS in Thousands) | - | 142.00 | 145.00 | ||||||||||||
BioSolutions - Industrial Sales Volume (MTDS in Thousands) Growth | - | -2.07% | 7.41% | ||||||||||||
BioSolutions - Total Sales Volume (MTDS in Thousands) | 327.00 | 330.00 | 327.00 | ||||||||||||
BioSolutions - Total Sales Volume (MTDS in Thousands) Growth | -0.91% | 0.92% | 6.17% | ||||||||||||
BioMaterials - Gross Average Sales Price per MT | - | 17.68K | 16.34K | ||||||||||||
BioMaterials - Gross Average Sales Price per MT Growth | - | 8.17% | -1.11% | ||||||||||||
BioMaterials - Sales Volume (MT in Thousands) | 150.30 | 146.40 | 159.90 | ||||||||||||
BioMaterials - Sales Volume (MT in Thousands) Growth | 2.66% | -8.44% | 10.81% | ||||||||||||
High Specialised % of Total Cellulose Product Sales Volume | - | 87.00% | 83.00% |
Updated Apr 29, 2026. Data Source: Fiscal.ai.